Related Experiment Video
Updated: Aug 6, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
The Treatment-Related Burnout Scale for Rheumatic Diseases: Development and Preliminary Validation
Gulsah Yasa Ozturk1, Burhan Fatih Kocyigit2, Huseyin Selvi3
1Department of Physical Medicine and Rehabilitation, University of Health Sciences, Adana City Research and Training Hospital, Adana, Türkiye.
A new scale measures treatment-related burnout in rheumatic diseases, finding moderate burnout levels, particularly emotional and cognitive exhaustion. This tool aids clinical assessment and research into patient psychosocial burden.
Area of Science:
- Rheumatology
- Psychology
- Health Sciences
Background:
- Treatment-related burnout is a significant concern for patients with chronic rheumatic diseases.
- Existing instruments may not adequately capture the multifaceted nature of burnout in this population.
Purpose of the Study:
- To develop and validate the Treatment-Related Burnout Scale for Rheumatic Diseases (TBS-RD).
- To assess burnout levels and associated factors in patients with rheumatologic diseases.
Main Methods:
- Methodological and descriptive study involving two independent patient samples.
- Scale development via literature review and expert consultation, followed by content validity assessment (Davis technique).
- Exploratory and confirmatory factor analyses, reliability (Cronbach's alpha, composite reliability) and validity (average variance extracted) assessments.
Main Results:
- The final 28-item TBS-RD demonstrated a four-factor structure (Emotional/Cognitive Exhaustion, Treatment-Related Exhaustion, Functional Burden, Healthcare System Burden).
- The scale exhibited satisfactory reliability (Cronbach's alpha = 0.966) and construct validity.
- Patients reported moderate treatment-related burnout, with emotional and cognitive exhaustion being the most prevalent dimension.
Conclusions:
- The TBS-RD is a valid and reliable multidimensional instrument for assessing treatment-related burnout in rheumatologic diseases.
- The scale can enhance clinical assessment and research by evaluating the psychosocial burden of long-term treatment.
- Findings underscore the need for individualized, psychosocially informed clinical management, noting gender as a significant factor in burnout.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
